Zobrazeno 1 - 10
of 238
pro vyhledávání: '"Paul J Fitzgerald"'
Autor:
Kevin Gournay
Publikováno v:
Mental Health Practice. 11:22-23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee36c99ce5893b0185f5a5417122ac1
https://doi.org/10.7748/mhp.11.7.22.s28
https://doi.org/10.7748/mhp.11.7.22.s28
Autor:
Paul J. Fitzgerald
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 15 (2021)
Major depressive disorder (MDD) remains a significant public health problem worldwide, and revised treatment strategies are therefore urgently needed, including the creation of novel antidepressant compounds or using existing molecular entities in ne
Externí odkaz:
https://doaj.org/article/fc2089f9b6d143beae6e8f8f8bf969fa
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
The anesthetic drug ketamine has been successfully repurposed as an antidepressant in human subjects. This represents a breakthrough for clinical psychopharmacology, because unlike monoaminergic antidepressants, ketamine has rapid onset, including in
Externí odkaz:
https://doaj.org/article/d56865f7b2f04e649b71a381d9fcc523
Publikováno v:
Social Work in Mental Health. 7:425-425
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27b6dd6f58fa53c19d617fa92737914e
https://doi.org/10.1080/15332980802434944
https://doi.org/10.1080/15332980802434944
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 14 (2021)
When stress becomes chronic it can trigger lasting brain and behavioral changes including Major Depressive Disorder (MDD). There is conflicting evidence regarding whether acetylcholinesterase inhibitors (AChEIs) may have antidepressant properties. In
Externí odkaz:
https://doaj.org/article/10b149d3eaa547dfa682a932d2dcd4d4
Autor:
Paul J. Fitzgerald
Publikováno v:
Molecules, Vol 27, Iss 9, p 2726 (2022)
Previous studies in animals and humans have shown multiple types of interaction between alcohol (ethanol) intake and the catecholamine signaling molecules: dopamine, norepinephrine and epinephrine. This literature suggests that the administration of
Externí odkaz:
https://doaj.org/article/51bdcd3951d9416991345e0098152275
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215554 (2019)
Major depression is a stress-linked disease with significant morbidity and the anesthetic drug ketamine is of growing interest in the treatment of depression, since in responsive individuals a single dose has rapid (within hours) antidepressant effec
Externí odkaz:
https://doaj.org/article/16fac2738b3d420ca514184aa6f50fa5
Autor:
Brendon O. Watson, Joanna L. Spencer-Segal, Paul J. Fitzgerald, Ali Gheidi, Jonathan D. Morrow, Savannah K Kounelis-Wuillaume
Publikováno v:
Stress
Ketamine has emerged as a novel treatment for common psychiatric conditions such as Major Depressive Disorder (MDD) and anxiety disorders, many of which can be initiated and exacerbated by psychological stress. Sex differences in the frequency of bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::264e2896cc55bf9579e3bd6769ce573c
https://doi.org/10.1080/10253890.2021.1871600
https://doi.org/10.1080/10253890.2021.1871600
Autor:
Paul J. Fitzgerald
Publikováno v:
Substance Abuse: Research and Treatment, Vol 2013, Iss 7, Pp 171-183 (2013)
Externí odkaz:
https://doaj.org/article/e6c63483af494c6c8aa420f22dc19af8